Search for: "Philips Lighting Electronics Company"
Results 81 - 94
of 94
Sort by Relevance
|
Sort by Date
27 Jun 2008, 10:04 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Court reconsidering baseless ‘making available’ theory in file-sharing case Capitol Records v Jammie Thomas; amicus briefs from, MPAA, PFF: (Electronic Frontier Foundation), (Electronic Fontier Foundation), (Techdirt), (Ars Technica), (Patry Copyright Blog), (Patry Copyright Blog) ICANN approves rules allowing brands… [read post]
13 Jun 2008, 3:40 am
, (IPKat), (IPKat), (Class 46), (IPKat), (IP Law360), Quanta – Supreme Court reverses CAFC decision in Quanta v LG Electronics; method patents exhaustible: (Peter Zura's 271 Patent Blog), (IP Updates), (Hal Wegner), (Patently-O), (Techdirt), (Patent Prospector), (Ars Technica), (Patent Docs), (Agricultural Law Blog), (Filewrapper), (Intellectual Property Law Blog), (Philip Brooks), (Philip Brooks guest blog), (IP ThinkTank), (Electronic Frontier… [read post]
30 May 2008, 9:09 am
: (Spicy IP), India: DCGI preparing document to implement patent-registration linkage: (Spicy IP), New Zealand: Generic pharmaceutical companies taking advantage of NZ IP laws and medicines regulations: (International Law Office), Uganda: Cipla licenses ARV technology into Uganda: (Afro-IP), US: Money saved through generic prescriptions: (GenericsWeb), US: Government plans to keep close tab on drug patent settlements: (GenericsWeb), US: FTC reports 14 deals to delay generics in 2007:… [read post]
9 May 2008, 10:30 pm
: (Afro-IP), (Managing Intellectual Property), Rwanda: Four years after AIDS drugs bill passed, first low cost meds may head to Rwanda: (GenericsWeb), US: Abbott’s first quarter lobbying tab hits $880,000: (Patent Docs), US: House Bill would expand federal drug pedigree requirements and preempt state requirements: (FDA Law Blog), US: Purchasing Canadian drugs and patent infringement: Litecubes decision: (Patently-O), US: Neuralstem seeks to reopen stayed patent case… [read post]
2 May 2008, 7:00 am
Landmark IP implications for universities: University of Western Australia v Gray: (IPRoo), (Managing Intellectual Property), (The Age), The latest edition of US Trade Representative’s ‘Special 301 Report’: (Ars Technica), (Ars Technica), (IAM), (Intellectual Property Watch), (Patry Copyright Blog), (Managing Intellectual Property), (Patent Docs), (IP Law360), Court rejects RIAA ‘making available’ theory: Atlantic v Howell:… [read post]
28 Apr 2008, 11:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC vacates FTC’s decision that Rambus breached antitrust duty by violating JEDEC patent disclosure rules and orders new trial: (Philip Brooks), (Techdirt), (Ars Technica), (IP Law360), (Peter Zura's 271 Patent Blog), (Hal Wegner), (IPBiz), (IP Law360), UK Court of Appeal rules on whether prior art not in the same design… [read post]
18 Apr 2008, 2:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Ranbaxy and AstraZeneca reach agreement in Esomeprazole patent litigation: (SmartBrief), (IPBiz), (Spicy IP), (Profitability through Simplicity), (IP Law360), (Philip Brooks), (GenericsWeb), Cadbury loses Australian battle over exclusive use of colour purple for chocolate wrapping in its case against Darrell Lea: (Australian Trade Marks… [read post]
11 Apr 2008, 9:00 am
Forest Laboratories, Inc. turns law of declaratory judgment on its head: (Patent Docs), (Patent Baristas), Mircera (Methoxy polyethylene glycol-epoetin beta) – Roche appeals preliminary injunction barring US sales of Mircera in patent infringement battle with Amgen: (Philip Brooks), (IP Law360), Norvasc (Amlodipine) – Ranbaxy becomes first foreign generic company to develop a generic product independently outside Japan and receive authorization from… [read post]
28 Mar 2008, 6:00 am
: (IPEG),Proponents: Slow better than poor for WIPO Development Agenda: (Intellectual Property Watch),Chatham House Rule comes to WIPO Development Agenda: (IP Updates),New campaign by a group of Second Life Avatars to raise awareness of the ‘theft’ of virtual items: (IPKat), (Patry Copyright Blog),World IP Day is on the way: (IPKat),Watch for IP leaks from publications: (Securing Innovation),Lessig’s (Government) FOSS market: (IPcentral.info),Notions of free:… [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey shows most Americans… [read post]
16 Nov 2007, 4:00 am
: (IP Dragon),Adidas-Salamon AG recently won a suit for unfair competition in China against two Chinese footwear manufacturing companies: (Post Grant Opposition),Patent litigation in China: (Ladas & Parry), (Philip Brooks), DenmarkLego loses trade mark case at home in Denmark: (IPFactor), EuropeThe battle for Magenta and colour marks in Europe: (IPKat), (richlicki), EPO Board of Appeals cases database updated: (EPO), Will the EU Community Patent get a final chance? [read post]
31 Oct 2007, 4:02 pm
The zone has 276 registered electronic and information enterprises, 42 pharmaceutical, 57 light machinery companies, and 32 new material companies. [read post]
20 Aug 2007, 8:36 am
Below we have presented some useful statistics that shed greater light on who's blogging, how much of it they're doing and other trends of law blogs today. [read post]
5 Feb 2007, 7:46 pm
The imponderable substances are destitute of weight, as light, caloric, electricity, and magnetism. [read post]
